Evidence map›Paper›PMID 22866980›Full record

ArticleBiomedical engineering online2012

Using stochastic modelling to identify unusual continuous glucose monitor measurements and behaviour, in newborn infants.

Matthew Signal, Aaron Le Compte, Deborah L Harris, Phil J Weston, Jane E Harding, J Geoffrey Chase, CHYLD Study Group

Open access · goldAbstract read
In one paragraph

Article in Biomedical engineering online, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 16 citations in OpenAlex.

  1. Continuous glucose monitoring in neonates: a review.Maternal health, neonatology and perinatology · 2017
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Matthew SignalDepartment of Mechanical Engineering, University of Canterbury, Christchurch, New Zealand.
Aaron Le Compte
Deborah L Harris
Phil J Weston
Jane E Harding
J Geoffrey Chase
CHYLD Study Group
University of Canterbury · NZWaikato District Health Board · NZUniversity of Auckland · NZ

Funding

Children with Hypoglycemia and their Later Development (the CHYLD Study)R01HD069622 · NICHD · UNIVERSITY OF AUCKLAND · PI HARDING, JANE · 2011 to 2015
$1.7M
NICHD NIH HHS R01HD069622
6 · The paper itself

Abstract

backgroundAbnormal blood glucose (BG) concentrations have been associated with increased morbidity and mortality in both critically ill adults and infants. Furthermore, hypoglycaemia and glycaemic variability have both been independently linked to mortality in these patients. Continuous Glucose Monitoring (CGM) devices have the potential to improve detection and diagnosis of these glycaemic abnormalities. However, sensor noise is a trade-off of the high measurement rate and must be managed effectively if CGMs are going to be used to monitor, diagnose and potentially help treat glycaemic abnormalities.

aimTo develop a tool that will aid clinicians in identifying unusual CGM behaviour and highlight CGM data that potentially need to be interpreted with care.

methodsCGM data and BG measurements from 50 infants at risk of hypoglycaemia were used. Unusual CGM measurements were classified using a stochastic model based on the kernel density method and historical CGM measurements from the cohort. CGM traces were colour coded with very unusual measurements coloured red, highlighting areas to be interpreted with care. A 5-fold validation of the model was Monte Carlo simulated 25 times to ensure an adequate model fit.

resultsThe stochastic model was generated using ~67,000 CGM measurements, spread across the glycaemic range ~2-10 mmol/L. A 5-fold validation showed a good model fit: the model 80% confidence interval (CI) captured 83% of clinical CGM data, the model 90% CI captured 91% of clinical CGM data, and the model 99% CI captured 99% of clinical CGM data. Three patient examples show the stochastic classification method in use with 1) A stable, low variability patient which shows no unusual CGM measurements, 2) A patient with a very sudden, short hypoglycaemic event (classified as unusual), and, 3) A patient with very high, potentially un-physiological, glycaemic variability after day 3 of monitoring (classified as very unusual).

conclusionsThis study has produced a stochastic model and classification method capable of highlighting unusual CGM behaviour. This method has the potential to classify important glycaemic events (e.g. hypoglycaemia) as true clinical events or sensor noise, and to help identify possible sensor degradation. Colour coded CGM traces convey the information quickly and efficiently, while remaining computationally light enough to be used retrospectively or in real-time.

Indexed as

Data Interpretation, StatisticalModels, StatisticalBlood GlucoseFemaleHumansHypoglycemiaInfant, NewbornMaleMonitoring, PhysiologicReproducibility of ResultsRetrospective StudiesRiskStochastic ProcessesBlood Glucose

Identifiers

PMID22866980
PMCPMC3466145
OpenAlexW2160596559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.